Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion type Assertion NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_head.
- NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion description "[We analyzed TMPRSS2-ERG gene rearrangement status by fluorescence in situ hybridization in 521 cases of clinically localized surgically treated prostate cancer with 95 months of median follow-up and also in 40 unmatched metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_provenance.
- NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion evidence source_evidence_literature NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_provenance.
- NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion SIO_000772 19190343 NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_provenance.
- NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion wasDerivedFrom befree-20150227 NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_provenance.
- NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_assertion wasGeneratedBy ECO_0000203 NP383052.RA6Jf6X6zuenIN5Oh9yDMM_hFH_0jmn1yL25xo9FoQqNU130_provenance.